{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:31:15Z","timestamp":1790361075897,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005499","name":"Oncology Nursing Society Foundation","doi-asserted-by":"publisher","award":["RE01A"],"award-info":[{"award-number":["RE01A"]}],"id":[{"id":"10.13039\/100005499","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Vanderbilt University School of Nursing"}],"content-domain":{"domain":["ejoncologynursing.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Oncology Nursing"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.ejon.2014.07.006","type":"journal-article","created":{"date-parts":[[2014,9,2]],"date-time":"2014-09-02T01:09:30Z","timestamp":1409620170000},"page":"75-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Development and preliminary testing of head and neck cancer related external lymphedema and fibrosis assessment criteria"],"prefix":"10.1016","volume":"19","author":[{"given":"Jie","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila H.","family":"Ridner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary S.","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejon.2014.07.006_bib1","series-title":"Cancer facts & Figures\u00a02012","author":"American Cancer Society","year":"2012"},{"key":"10.1016\/j.ejon.2014.07.006_bib2","series-title":"Lymphedema: Understanding and Managing Lymphedema after Cancer Treatment","author":"American Cancer Society","year":"2006"},{"key":"10.1016\/j.ejon.2014.07.006_bib3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/PRS.0b013e3181adcf4b","article-title":"Fibrosis is a key inhibitor of lymphatic regeneration","volume":"124","author":"Avraham","year":"2009","journal-title":"Plastic and Reconstructive Surgery"},{"key":"10.1016\/j.ejon.2014.07.006_bib4","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1096\/fj.12-222695","article-title":"Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema","volume":"27","author":"Avraham","year":"2012","journal-title":"Federation of American Societies for Experimental Biology Journal"},{"key":"10.1016\/j.ejon.2014.07.006_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1053-4296(03)00036-5","article-title":"Normal tissue effects: reporting and analysis","volume":"13","author":"Bentzen","year":"2003","journal-title":"Seminars in Radiation Oncology"},{"key":"10.1016\/j.ejon.2014.07.006_bib6","article-title":"Oncology Nursing Society, ONS Foundation Endowment","author":"Berger","year":"2009","journal-title":"Research Agenda"},{"key":"10.1016\/j.ejon.2014.07.006_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-3284-2-15","article-title":"Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)","volume":"2","author":"Dayyani","year":"2010","journal-title":"Head and Neck Oncology"},{"key":"10.1016\/j.ejon.2014.07.006_bib8","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/hed.23084","article-title":"Impact of secondary lymphedema after HNC treatment on symptoms, functional status, and quality of life","volume":"35","author":"Deng","year":"2013","journal-title":"Head and Neck"},{"key":"10.1016\/j.ejon.2014.07.006_bib9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1188\/13.ONF.501-506","article-title":"Assessment of external lymphedema in patients with HNC: a comparison of four scales","volume":"40","author":"Deng","year":"2013","journal-title":"Oncology Nursing Forum"},{"key":"10.1016\/j.ejon.2014.07.006_bib10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jpainsymman.2011.03.019","article-title":"Prevalence of secondary lymphedema in patients with head and neck cancer","volume":"43","author":"Deng","year":"2012","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1016\/j.ejon.2014.07.006_bib11","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1188\/11.ONF.E1-E10","article-title":"Lymphedema in patients with head and neck cancer","volume":"38","author":"Deng","year":"2011","journal-title":"Oncology Nursing Forum"},{"key":"10.1016\/j.ejon.2014.07.006_bib12","first-page":"CD005037","article-title":"Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients","volume":"3","author":"Dennert","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.ejon.2014.07.006_bib13","series-title":"Scale Development: Theory and Applications","author":"DeVellis","year":"2003"},{"key":"10.1016\/j.ejon.2014.07.006_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus\u2013positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.ejon.2014.07.006_bib15","series-title":"F\u00f6ldi's Textbook of Lymphology: for Physicians and Lymphedema Therapists","author":"F\u00f6ldi","year":"2007"},{"key":"10.1016\/j.ejon.2014.07.006_bib16","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1634\/theoncologist.2012-0286","article-title":"Induction chemotherapy for locoregionally advanced head and neck cancer: past, present, future?","volume":"18","author":"Hanna","year":"2013","journal-title":"The Oncologist"},{"key":"10.1016\/j.ejon.2014.07.006_bib17","series-title":"Best Practice of the Management of Lymphoedema. International Consensus","author":"Lymphoedema Framework","year":"2006"},{"key":"10.1016\/j.ejon.2014.07.006_bib18","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1586\/14737140.7.7.1043","article-title":"Systemic and global toxicities of head and neck treatment","volume":"7","author":"Murphy","year":"2007","journal-title":"Expert Review of Anticancer Therapy"},{"key":"10.1016\/j.ejon.2014.07.006_bib19","series-title":"HPV Connection, the Human Papilloma Virus","author":"Oral Cancer Foundation","year":"2012"},{"key":"10.1016\/j.ejon.2014.07.006_bib20","doi-asserted-by":"crossref","first-page":"vii246","DOI":"10.1093\/annonc\/mdq291","article-title":"Integrating systemic agents into multimodality treatment of locally advanced head and neck cancer","volume":"21","author":"Posner","year":"2010","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.ejon.2014.07.006_bib21","first-page":"1","article-title":"Lymphedema of the head and neck: an overview","volume":"20","author":"Ridner","year":"2008","journal-title":"National Lymphedema Network Link"},{"key":"10.1016\/j.ejon.2014.07.006_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/MOO.0b013e3283393799","article-title":"Lymphedema management in head and neck cancer","volume":"18","author":"Smith","year":"2010","journal-title":"Current Opinion in Otolaryngology & Head and Neck Surgery"},{"key":"10.1016\/j.ejon.2014.07.006_bib23","series-title":"Common Terminology Criteria for Adverse Events v3.0 (CTCAE)","author":"United States Department of Health and Human Services","year":"2006"},{"key":"10.1016\/j.ejon.2014.07.006_bib24","series-title":"Head and Neck Cancers","author":"United States Department of Health and Human Services","year":"2012"}],"container-title":["European Journal of Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388914001021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388914001021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T04:30:48Z","timestamp":1538281848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1462388914001021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1462388914001021"],"URL":"https:\/\/doi.org\/10.1016\/j.ejon.2014.07.006","relation":{},"ISSN":["1462-3889"],"issn-type":[{"value":"1462-3889","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and preliminary testing of head and neck cancer related external lymphedema and fibrosis assessment criteria","name":"articletitle","label":"Article Title"},{"value":"European Journal of Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejon.2014.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}